Aditya Bagrodia, M.D., F.A.C.S

Professor

About Dr. Bagrodia

Dr. Aditya Bagrodia is a Professor in the Departments of Urology and Radiation Medicine & Applied Sciences. He serves as the Moores Cancer Center Disease Team Co-Leader for Genitourinary Cancers.

A fellowship-trained urologic oncologist whose practice spans the full spectrum of urologic malignancies, including adrenal, upper tract, renal, bladder, prostate, penile, and testicular cancers, Dr. Bagrodia has particular expertise in the complex multidisciplinary management of patients with advanced disease, employing both open and minimally invasive surgical techniques. A central area of his clinical practice is the management of germ cell tumors, with a focus on testicular cancer, where he integrates surgical care with systemic therapy and long-term survivorship considerations. His work emphasizes patient-centered, evidence-based care for individuals with both common and rare urologic cancers.

Dr. Bagrodia’s research program is centered on germ cell tumors, with particular attention to testicular cancer biology, treatment resistance, and socio-epidemiologic determinants of outcome. His laboratory employs genomic and translational approaches, including sequencing, biomarker discovery, and model systems such as zebrafish and murine platforms, to investigate tumor heterogeneity, evolution, and mechanisms of cisplatin resistance. He leads several clinical trials directed at improving outcomes in germ cell tumors and is actively engaged in efforts to identify novel strategies for detecting and treating minimal residual disease. His research is supported by NIH, CPRIT, and foundation funding, and he has authored more than 100 peer-reviewed publications, contributing significantly to the understanding and management of testicular cancer.